Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoid-remediable aldosteronism

W R Litchfield1, R G Dluhy, R P Lifton

  • 1Endocrinology-Hypertension Division, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Comprehensive Therapy
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Phenotypic spectrum of autosomal recessive congenital ichthyosis due to PNPLA1 mutation.

The British journal of dermatology·2017
Same author

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons.

Molecular psychiatry·2014
Same author

Serial exome analysis of disease progression in premalignant gammopathies.

Leukemia·2014

Glucocorticoid-remediable aldosteronism (GRA) is likely underdiagnosed but advances in genetic testing simplify diagnosis. Early detection and treatment of GRA can reduce hypertension-related complications.

Area of Science:

  • Endocrinology
  • Genetics
  • Hypertension Research

Background:

  • Glucocorticoid-remediable aldosteronism (GRA) is considered rare but likely underdiagnosed.
  • Recent advances in understanding GRA pathogenesis have expanded knowledge of this disorder.
  • Mineralocorticoid-induced hypertension requires a high index of suspicion for GRA.

Purpose of the Study:

  • To highlight the underdiagnosis of GRA.
  • To emphasize the impact of recent advances in GRA pathogenesis.
  • To advocate for early detection and treatment of GRA.

Main Methods:

  • Review of recent advances in GRA pathogenesis.
  • Discussion of the role of direct genetic testing in GRA diagnosis.
  • Clinical guidelines for managing mineralocorticoid-induced hypertension.

Related Experiment Videos

Main Results:

  • Direct genetic testing simplifies the diagnostic approach to GRA.
  • Increased detection of previously undiagnosed GRA cases is anticipated.
  • Appropriate treatment can normalize refractory hypertension associated with GRA.

Conclusions:

  • A high index of suspicion for GRA is crucial in patients with mineralocorticoid-induced hypertension.
  • Early detection and targeted treatment of GRA can significantly reduce associated morbidity and mortality.
  • Advances in genetic testing are expected to improve GRA diagnosis rates.